The CAD group had higher serum TG, LDL-C, Lp(a), APO-B, and hs-CRP levels; WBC and neutrophil counts; and monocyte counts than did the non-CAD group (P < 0.05). This evidence concerns the gene MAP3K14 and coronary artery disorder.